The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...
On today’s CT BUZZ, Host Natasha Lubczenko sat down with Dr. Zach Korwin, owner of Sleep Stratford, to discuss an innovative ...
The directive for the Department of Health and Human Services to develop and test new models aimed at lowering drug costs ...
Medicare covers sleep tests for certain conditions such as sleep apnea, narcolepsy, or parasomnia, but limitations may apply.
Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company.
Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...
The popular weight-loss drugs were added to Medicare’s list of prices negotiated directly between the government and drug ...
Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health ...
Announcement of the 15 medicines chosen for the second round of negotiations was one of the Biden administration’s final ...
Sleep apnea is a disorder that happens when your ... Typically, if you have Medicare and meet your deductible, 80% of your costs for approved medical equipment will be covered.
Sleep apnea is a condition that causes repeated cycles of breathing interruptions during sleep. If left untreated, sleep apnea may lead to dangerous health complications related to oxygen deprivation.
A study on traditional Medicare beneficiaries found that more of those had coverage for supplemental services compared to those with Medicare Advantage (MA). Spending and use were similar.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback